The Market Opportunity

An untapped $30B+ market at the intersection of faith, wellness, and plant medicine.

Explosive Growth

The cannabis industry is experiencing exponential growth, creating a landmark investment opportunity.

$41 Billion
US Cannabis Market by 2025
Arcview Market Research / BDS Analytics
$20 Billion
US CBD Market by 2024
Nielsen
$7 Billion
California Market by 2024
BDS Analytics

Global Market Explosion

The cannabis and wellness markets are experiencing unprecedented growth across all segments

2024
$69.78B
2033
$216.8B
13.5% CAGR

Global Legal Cannabis Market

Explosive growth in regulated cannabis markets worldwide

2024
$41.95B
2033
$290.7B
24% CAGR

Total Cannabis Market

Including all segments: medical, recreational, and emerging spiritual

2024
$8.28B
2034
$46.25B
16.9% CAGR

Hemp-Derived CBD Market

Massive expansion in wellness-focused CBD products

2024
$13.94B
2034
$73.28B
18% CAGR

Cannabis Extract Market

Oils, tinctures, concentrates — premium product segment

2024
$1.5B
2030
$3.1B
13.5% CAGR

North America Hemp CBD

U.S. and Canada leading the wellness revolution

Real-World Example: Illinois

Legal cannabis sales in 2024 topped $2 billion

Up 2.5% from 2023 — in just one state

Federal Rescheduling: The Game Changer

Trump administration moves toward cannabis rescheduling — creating unprecedented opportunity for compliant, values-driven brands

What's Happening

The Trump administration has signaled support for rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act

DEA review process is underway, with bipartisan momentum building for federal reform

Expected timeline: 2025-2026 for formal rescheduling implementation

Banking reform (SAFE Act) likely to pass alongside rescheduling, opening institutional capital

Massive Tax Relief

Schedule III rescheduling eliminates IRS 280E, allowing cannabis businesses to deduct normal business expenses. This changes profitability overnight and makes cannabis companies investable for institutional capital.

Translation: Margins improve 20-40% immediately

Banking Access

Federal banking reform means cannabis companies can access traditional banking, credit cards, and institutional investment without legal risk. The floodgates open.

Translation: Private equity, venture capital, and public markets become accessible

Interstate Commerce

Schedule III potentially opens pathways for interstate cannabis commerce, allowing compliant brands to scale nationally instead of state-by-state. Our hemp + THC-A lines are already positioned for this.

Translation: National brands can finally exist at scale

Mainstream Acceptance

Federal rescheduling legitimizes cannabis for conservative consumers who were waiting for government approval. This is our audience — faith-driven, values-oriented, mainstream America.

Translation: The biggest consumer base finally enters the market

Why Spiritual Plants Wins Big

We've built the only spiritual cannabis platform in America while everyone else was racing to the bottom on price and potency. When rescheduling happens, mainstream consumers will flood the market — and they'll be looking for brands they can trust.

We're not just early. We're the category.

What This Means for Spiritual Plants

We're positioned at the intersection of the fastest-growing segments

Massive Scale

Legal cannabis & extract markets are already tens of billions and poised for rapid growth. Your ecosystem steps into a large, expanding field with proven demand.

High Growth Segments

CBD and cannabis extracts show 15-18%+ CAGRs, indicating massive opportunity for differentiated, premium-value offerings like our spiritual brands.

Regional Traction

North America dominates CBD/hemp markets. Our California operations and Orange County clinics position us perfectly in the strongest market.

Product & Service Convergence

With extracts, wellness practices, and AI integration, our model—clinics + digital + technology—aligns perfectly with where these markets are moving.

The Underserved Faith-Driven Consumer

A massive, values-oriented market is actively seeking brands that resonate with their worldview. Currently, there are zero trusted Christian cannabis brands.

41 Million

Faith-driven consumers in the U.S.

$2 Trillion

Annual buying power

83%

Switch brands for a better, value-aligned option

"85% of faith-driven consumers don't feel welcomed by their current brands."

- Faith Driven Consumer 2020

Industry Comparables

Similar-stage companies have commanded premium valuations

Lord Jones

Acquisition$300M
Revenue$9M
Multiple33x

Select

Acquisition$950M
RevenueN/A
MultiplePremium

Papa & Barkley

Acquisition$100M+
RevenueN/A
MultiplePremium

Momentum Timeline

From cultural disruption to industry domination

Apr 2019

Coachella Skywriting

The 'Jesus Loves Weed' signal over Coachella sparked global conversation and marked the public beginning of the movement.

Dec 2019

MJBizCon Industry Debut

The Christian Cannabis concept was formally introduced to the industry, announcing the mission to bridge faith and cannabis.

Apr 2025

Resurrection: Licensed Launch

The official launch of licensed Christian Cannabis products, culminating the journey from signal to regulated spiritual wellness.

Dec 2025

Christian CBD Christmas Launch

Nationwide launch of Christian CBD wellness line with Holy Roll-on and Sleep Capsules, available on SpiritualPlants.com and Amazon.

2026

National Hemp Expansion

Launch of Spiritual Plants hemp and THC-A lines including Heaven's Hemp, Saints, Mormon Meds, Diosa, and Pure Joy — shipping nationwide.

2026+

Multi-State Licensing Deals

Strategic licensing partnerships across multiple states to produce and distribute Christian Cannabis Communion Wafers and Red Rose Spritzer drink.

The Window is Now

First mover in a $30B+ untapped market. Proven team. Complete infrastructure. Zero direct competition. This opportunity won't exist in 12 months.